GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (XTER:QIA) » Definitions » Cyclically Adjusted PB Ratio

Qiagen NV (XTER:QIA) Cyclically Adjusted PB Ratio : 2.86 (As of Apr. 27, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Qiagen NV's current share price is €38.76. Qiagen NV's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €13.57. Qiagen NV's Cyclically Adjusted PB Ratio for today is 2.86.

The historical rank and industry rank for Qiagen NV's Cyclically Adjusted PB Ratio or its related term are showing as below:

XTER:QIA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.08   Med: 2.96   Max: 4.53
Current: 2.78

During the past years, Qiagen NV's highest Cyclically Adjusted PB Ratio was 4.53. The lowest was 2.08. And the median was 2.96.

XTER:QIA's Cyclically Adjusted PB Ratio is ranked worse than
66.41% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.98 vs XTER:QIA: 2.78

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Qiagen NV's adjusted book value per share data for the three months ended in Dec. 2023 was €15.774. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €13.57 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Qiagen NV Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Qiagen NV's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Cyclically Adjusted PB Ratio Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.74 4.28 4.27 3.50 2.99

Qiagen NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.50 3.23 3.13 2.78 2.99

Competitive Comparison of Qiagen NV's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Qiagen NV's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Cyclically Adjusted PB Ratio falls into.



Qiagen NV Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Qiagen NV's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=38.76/13.57
=2.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qiagen NV's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Qiagen NV's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=15.774/126.4000*126.4000
=15.774

Current CPI (Dec. 2023) = 126.4000.

Qiagen NV Quarterly Data

Book Value per Share CPI Adj_Book
201403 9.043 99.390 11.501
201406 9.299 99.240 11.844
201409 9.631 99.960 12.178
201412 9.915 99.050 12.653
201503 10.503 99.750 13.309
201506 10.380 100.230 13.090
201509 10.316 100.500 12.975
201512 10.823 99.730 13.717
201603 10.811 100.310 13.623
201606 10.673 100.260 13.456
201609 10.855 100.570 13.643
201612 11.281 100.710 14.159
201703 10.288 101.440 12.819
201706 10.072 101.370 12.559
201709 9.807 102.030 12.149
201712 9.770 101.970 12.111
201803 9.491 102.470 11.707
201806 9.810 103.100 12.027
201809 9.869 103.950 12.000
201812 10.588 103.970 12.872
201903 10.476 105.370 12.567
201906 10.605 105.840 12.665
201909 10.198 106.700 12.081
201912 10.334 106.800 12.231
202003 10.189 106.850 12.053
202006 10.501 107.510 12.346
202009 10.374 107.880 12.155
202012 10.400 107.850 12.189
202103 10.805 108.870 12.545
202106 11.145 109.670 12.845
202109 11.617 110.790 13.254
202112 12.442 114.010 13.794
202203 13.335 119.460 14.110
202206 14.059 119.050 14.927
202209 15.217 126.890 15.158
202212 14.815 124.940 14.988
202303 15.037 124.720 15.240
202306 15.111 125.830 15.179
202309 15.637 127.160 15.544
202312 15.774 126.400 15.774

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Qiagen NV  (XTER:QIA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Qiagen NV Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV (XTER:QIA) Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (XTER:QIA) Headlines

No Headlines